InnAVasc Medical said it raised $2.15 million in a new round of equity financing, according to an SEC filing posted today .
InnAVasc is developing devices designed for vascular access during hemodialysis.
The company’s 1st device is an arteriovenous graft modification which includes 2 multilayer cannulation chambers and low-bleed tech, designed to be resistant to posterior and sidewall needle penetration and injury, according to its website.
The company said it is on the path for 510(k) submission, and has established a manufacturing partner for device finalization over the past year.
Money in the round came from 39 anonymous sources, according to the SEC Filing, and the company is looking to raise an additional $1.1 million before closing it.
The company has not yet stated how it plans to use funds raised in the round.